Carevature Revenue and Competitors

Carevature Medical was founded with a primary goal to improve the tools available to spine surgeons for spinal decompression. Decompression of the neural elements and/or spinal canal is the most critical aspect of surgical intervention for degenerative spinal conditions, and yet for decades there has been little to no innovation in improving the tools for spinal decompression (Kerrisons, osteotomes, etc.). Numerous advancements in implant technology, navigation, and robotics have been introduced in recent years, however surgeons are still largely using the same tools for spinal decompression that have been used since the 1980s. Carevature is changing this with Dreal® technology, a platform of sterile packed, single use, curved at the tip, high-speed bone removal devices that are shielded to protect nearby neural structures. Dreal® technology allows spine surgeons to decompress the neural elements while retaining structural bone, preserving spinal stability and in some cases, offering the potential to avoid spinal fusion. The devices are optimized for MIS tubular approaches, with versions for mini-open and open techniques as well. Dreal® technology can be used in numerous applications, including ACDF, Cervical Corpectomy, Facet-preserving Lumbar foraminotomy, endplate prep for TLIF, MIS removal of thoracic hard disc pathology, and many others. Potential benefits of the Dreal® platform include safer, faster, and more efficient spinal procedures, as well as the possibility to avoid fusion in select cases, and the resulting opportunity for shorter hospital stays and a quicker return to work and/or the activities of daily living.